Live from the NIH registry
Studies recruiting near Lakeland right now
Top 25 of 191 recruiting studies, sorted by proximity — each links to its official registry page
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
Lymphoma, Non-Hodgkin, Multiple Myeloma
Phase 2
Interventional 4,200 participants sought
Florida Cancer Specialists North / Sarah Cannon Research Institute — Brandon, Florida (21.8 mi)
· Sponsor: American Society of Clinical Oncology
The GORE VBX FORWARD Clinical Study: A Comparison of the GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis to Bare Metal Stenting for Patients With Complex Iliac Occlusive Disease
Aortoiliac Occlusive Disease, Peripheral Arterial Disease
N/A
Interventional 244 participants sought
Radiology and Imaging Specialists of Lakeland — Lakeland, Florida (1.2 mi)
· Sponsor: W.L.Gore & Associates
A Study Evaluating Disease Characteristics and Outcomes in Participants With Asthma in Routine Clinical Practice
Asthma
N/A
Observational 2,500 participants sought
Meris Clinical Research - Site Number: 840167 — Brandon, Florida (21.8 mi)
· Sponsor: Sanofi
Secukinumab Open Label Roll-over Extension Protocol
Autoimmunity, Inflammation
Phase 4
Interventional 1,000 participants sought
FL Medical Clinic Orlando Health — Zephyrhills, Florida (18.5 mi)
· Sponsor: Novartis Pharmaceuticals
A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease
Chronic Kidney Disease
Phase 2
Interventional 465 participants sought
Clinical Research of Cent FL — Winter Haven, Florida (13.7 mi)
· Sponsor: Novo Nordisk A/S
ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack
Cardiovascular Risk, Acute Myocardial Infarction (AMI)
Phase 3
Interventional 10,000 participants sought
Winter Haven Hospital — Winter Haven, Florida (13.7 mi)
· Sponsor: Novo Nordisk A/S
A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus
Systemic Lupus Erythematosus
Phase 3
Interventional 450 participants sought
Sl0044 50239 — Brandon, Florida (21.8 mi)
· Sponsor: UCB Biopharma SRL
A Study of Patients With Lower Extremity Acute Limb Ischemia to Remove Thrombus With the Indigo™ Aspiration System (STRIDE II)
Lower Extremity Acute Limb Ischemia, LE ALI
N/A
Observational 300 participants sought
Radiology and Imaging Specialists — Lakeland, Florida (1.2 mi)
· Sponsor: Penumbra Inc.
Study of Efficacy and Safety of LNP023 in Participants With Active Lupus Nephritis Class III-IV, +/- V
Lupus Nephritis
Phase 2
Interventional 240 participants sought
Florida Kidney Physicians — Riverview, Florida (26.2 mi)
· Sponsor: Novartis Pharmaceuticals
A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
Heart Failure
Phase 3
Interventional 4,200 participants sought
Bay Area Cardiology — Brandon, Florida (21.8 mi)
· Sponsor: Boehringer Ingelheim
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
Atherosclerotic Cardiovascular Disease, Overweight
Phase 3
Interventional 12,800 participants sought
Clinical Research of Central Florida — Lakeland, Florida (1.2 mi)
· Sponsor: Amgen
TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy
Transthyretin Amyloidosis With Cardiomyopathy
Phase 3
Interventional 1,750 participants sought
Clinical Trial Site — Brandon, Florida (21.8 mi)
· Sponsor: Alnylam Pharmaceuticals
A Phase 2 Neoadjuvant Study of Zanidatamab in Combination With Chemotherapy in Participants With HER2-positive Breast Cancer
HER2-positive Breast Cancer, Breast Cancer
Phase 2
Interventional 125 participants sought
The Oncology Institute — Lakeland, Florida (1.2 mi)
· Sponsor: Jazz Pharmaceuticals
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
NASH - Nonalcoholic Steatohepatitis, MASH - Metabolic Dysfunction-Associated Steatohepatitis
Phase 3
Interventional 2,150 participants sought
Akero Clinical Study Site — Zephyrhills, Florida (18.5 mi)
· Sponsor: Akero Therapeutics, Inc
Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms
Depressive Disorder, Major
Phase 3
Interventional 752 participants sought
Clinical Research of Brandon — Brandon, Florida (21.8 mi)
· Sponsor: Janssen Research & Development, LLC
Surabgene Lomparvovec Administered in the Suprachoroidal Space in Adult Participants With Diabetic Retinopathy Without Center-Involved Diabetic Macular Edema
Diabetic Retinopathy
Phase 2, Phase 3
Interventional 576 participants sought
Florida Retina Consultants - Lakeland /ID# 275012 — Lakeland, Florida (1.2 mi)
· Sponsor: AbbVie
Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer
Multiple conditions
Phase 2
Interventional 98 participants sought
Moffitt Cancer Center at Wesley Chapel — Wesley Chapel, Florida (26.1 mi)
· Sponsor: NRG Oncology
A Study to Assess Adverse Events and Effectiveness of Gel Stent (XEN63) Implantation Using Ab Interno and Ab Externo Approaches in Adult Participants With Glaucoma
Primary Open Angle Glaucoma
Phase 3
Interventional 130 participants sought
Brandon Eye Associates - Brandon /ID# 277074 — Brandon, Florida (21.8 mi)
· Sponsor: AbbVie
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
Diabetes Mellitus, Type 2, Hypertension
Phase 3
Interventional 11,800 participants sought
Clinical Research of Central Florida - Lakeland — Lakeland, Florida (1.2 mi)
· Sponsor: Boehringer Ingelheim
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
Metabolic Dysfunction-Associated Steatotic Liver Disease
Phase 3
Interventional 4,500 participants sought
Covenant Metabolic Specialists - Riverview — Riverview, Florida (26.2 mi)
· Sponsor: Eli Lilly and Company
GORE® TAG® Thoracic Branch Endoprosthesis Zone 0/1 Post-Approval Study
Aortic Arch Dissection, Aortic Arch Aneurysm
N/A
Interventional 125 participants sought
Lakeland Regional Medical Center — Lakeland, Florida (1.2 mi)
· Sponsor: W.L.Gore & Associates
Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread
Metastatic Breast Cancer, Metastatic Gastric Adenocarcinoma
Phase 1, Phase 2
Interventional 768 participants sought
Helios CR Inc — Lakeland, Florida (1.2 mi)
· Sponsor: Boehringer Ingelheim
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
Breast Carcinoma, Colorectal Carcinoma
N/A
Observational 2,000 participants sought
South Florida Baptist Hospital — Plant City, Florida (10.1 mi)
· Sponsor: Wake Forest University Health Sciences
Fibromyalgia Response With Esreboxetine Evaluated Using a Randomized Withdrawal Research Design
Fibromyalgia
Phase 3
Interventional 620 participants sought
Clinical Research Site — Lakeland, Florida (1.2 mi)
· Sponsor: Axsome Therapeutics, Inc.
The Golazo® Peripheral Atherectomy System for a Safe and Effective Atherectomy (GREAT Trial)
Peripheral Arterial Disease
N/A
Interventional 159 participants sought
Radiology and Imaging Specialists of Lakeland — Lakeland, Florida (1.2 mi)
· Sponsor: Nipro Vascular Innovations Americas, Inc